But "generally safe" doesn't mean "zero things to know." This guide covers every side effect reported in published research, who should be cautious, how tablets compare to injections, and exactly how to minimise any discomfort
Survodutide Active Compound is the Fastest Growing Segment of the GLP-1 Market During the Forecast Period Based on the active compound, the market is segmented into dulaglutide, liraglutide, orforglipron, retatrutide, semaglutide, survodutide, tirzepatide and other active compounds
Treatment discontinuation for GLP-1 receptor agonists was lower among patients with high BMI, while associations of similar magnitude were not observed for SGLT2 inhibitors
Since patients are generally more willing to accept that trade-off following massive weight loss versus, say, a 20-pound change, surgeons are engineering new lift techniques for people who have lost smaller amounts of weight rapidly on GLP-1s
Neuroprotective effects of a GIP analogue in the MPTP Parkinsons disease mouse model